SAN

83.43

+1.19%↑

MRK1

118.9

+2.06%↑

SHL.DE

43.61

+1.49%↑

ARGX

756.8

-1.66%↓

FRE

47.89

-0.06%↓

SAN

83.43

+1.19%↑

MRK1

118.9

+2.06%↑

SHL.DE

43.61

+1.49%↑

ARGX

756.8

-1.66%↓

FRE

47.89

-0.06%↓

SAN

83.43

+1.19%↑

MRK1

118.9

+2.06%↑

SHL.DE

43.61

+1.49%↑

ARGX

756.8

-1.66%↓

FRE

47.89

-0.06%↓

SAN

83.43

+1.19%↑

MRK1

118.9

+2.06%↑

SHL.DE

43.61

+1.49%↑

ARGX

756.8

-1.66%↓

FRE

47.89

-0.06%↓

SAN

83.43

+1.19%↑

MRK1

118.9

+2.06%↑

SHL.DE

43.61

+1.49%↑

ARGX

756.8

-1.66%↓

FRE

47.89

-0.06%↓

Home・Aandelen Lijst・Virbac SA

Virbac SA

Gesloten

SectorGezondheidszorg

339.5 0.3

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

331.5

Max

340.5

Belangrijke statistieken
By Trading Economics
Inkomsten	32M 82M
Verkoop	44M 738M
K/W Sectorgemiddelde	21.974 77.671
Dividendrendement	0.41
Winstmarge	11.162
Werknemers	6,365
EBITDA	41M 157M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+15.49% upside

Dividenden
By Dow Jones
Dividendrendement Sectorgemiddelde	0.41% 2.35%

Marktinformatie
By TradingEconomics
Marktkapitalisatie	285M 2.9B
Vorige openingsprijs	339.2
Vorige sluitingsprijs	339.5

Nieuwssentiment

By Acuity

23%

77%

71 / 374 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bearish Evidence

303.6 / 306.25 Steun & Weerstand

Virbac SA Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

10 dec 2025, 22:02 UTC

Winsten

Synopsys Sees Strong 2026 as Ansys Acquisition Boosts 4Q Revenue

10 dec 2025, 21:46 UTC

Winsten

Adobe Expects Double-Digit Recurring Revenue Growth Next Year

10 dec 2025, 23:52 UTC

Acquisities, Fusies, Overnames

Paramount Sends Letter to Warner Bros. Shareholders Saying Its Offer Is 'Superior' -- Barrons.com

10 dec 2025, 23:43 UTC

Marktinformatie

Nikkei May Rise After Fed Rate Cut -- Market Talk

10 dec 2025, 23:36 UTC

Marktinformatie

Gold Consolidates as Traders Digest FOMC Decision -- Market Talk

10 dec 2025, 23:20 UTC

Winsten

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- 2nd Update

10 dec 2025, 23:15 UTC

Winsten

Synopsys Targets Double-Digit Growth Following Ansys Acquisition -- Interview

10 dec 2025, 22:59 UTC

Marktinformatie

Winsten

Acquisities, Fusies, Overnames

Adobe Expects Semrush Deal to Bring in New Users -- Market Talk

10 dec 2025, 22:45 UTC

Marktinformatie

Coca-Cola's New CEO Pick Looks A Lot Like The Last One -- Market Talk

10 dec 2025, 22:40 UTC

Winsten

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10 dec 2025, 22:06 UTC

Acquisities, Fusies, Overnames

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10 dec 2025, 22:06 UTC

Winsten

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10 dec 2025, 22:02 UTC

Winsten

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10 dec 2025, 22:00 UTC

Winsten

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- Update

10 dec 2025, 21:53 UTC

Winsten

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10 dec 2025, 21:50 UTC

Acquisities, Fusies, Overnames

Investors Bet That a Higher Bid for Warner Is Coming -- Update

10 dec 2025, 21:50 UTC

Marktinformatie

Winsten

Acquisities, Fusies, Overnames

Financial Services Roundup: Market Talk

10 dec 2025, 21:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

10 dec 2025, 21:50 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

10 dec 2025, 21:45 UTC

Acquisities, Fusies, Overnames

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10 dec 2025, 21:33 UTC

Winsten

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- WSJ

10 dec 2025, 21:32 UTC

Winsten

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10 dec 2025, 21:28 UTC

Acquisities, Fusies, Overnames

Sverica Capital Management Announces Sale of Coastal Cloud Holdings to Tata Consultancy Services for $700M

10 dec 2025, 21:25 UTC

Winsten

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10 dec 2025, 21:18 UTC

Acquisities, Fusies, Overnames

Paramount Skydance: Company Has Air Tight Financing to Deliver on Warner Bros. Offer >PSKY

10 dec 2025, 21:16 UTC

Winsten

Oracle Reports Mixed Earnings. The Stock is Falling. -- Barrons.com

10 dec 2025, 21:15 UTC

Acquisities, Fusies, Overnames

Paramount Skydance: Public Offer for Warner Bros. Delivers Superior Value, Faster, More Certain Path to Completion

10 dec 2025, 21:15 UTC

Winsten

Oracle: 'Sold Ampere Because We No Longer Think It Is Strategic for Us to Continue Designing, Manufacturing and Using Our Own Chips in Our Cloud Datacenters' >ORCL

10 dec 2025, 21:14 UTC

Winsten

Oracle 2Q Non-GAAP Operating Income Was $6.7 B >ORCL

10 dec 2025, 21:14 UTC

Winsten

Oracle 2Q GAAP Operating Income Was $4.7 B >ORCL

Peer Vergelijking

Prijswijziging

Virbac SA Prognose

Koersdoel

By TipRanks

15.49% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 391.5 EUR 15.49%

Hoogste 415 EUR

Laagste 368 EUR

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Virbac SA - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

2 ratings

Buy

Hold

Sell

Gebaseerd op 2 analisten die aandelenratings hebben gegeven aan Virbac SA - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

303.6 / 306.25Steun & Weerstand

Recent bearish events outweigh bullish events.

All events are bullish.

Bearish events outweigh bullish events.

Sentiment

By Acuity

71 / 374 Rangschikking in Gezondheidszorg

Financieel

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Virbac SA

Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.